期刊文献+

MEKK3在结直肠癌组织中的表达及临床意义 被引量:1

Expression of MEKK3 and its clinical significance in human colorectal cancer
下载PDF
导出
摘要 目的研究MEKK3在人结直肠癌中的表达情况,分析MEKK3表达与结直肠癌临床分期、肿瘤位置、肿瘤大小、淋巴转移等临床病理特征的关系。方法应用免疫组织化学法检测59例结直肠癌组织及其癌旁正常组织中MEKK3的表达情况。结果 (1)MEKK3在结直肠癌组织和癌旁正常组织中的阳性表达率分别为83.1%和13.6%,结直肠癌组织中MEKK3的阳性率明显高于癌旁正常组织(P<0.05);(2)MEKK3的表达与性别、年龄、肿瘤位置、肿瘤大小、淋巴转移等临床病理特征不相关(P>0.05)。结论 MEKK3高表达是结直肠癌组织重要的分子事件。 Objective To study the expression of MEKK3 in colorectal cancer, and the relationship between MEKK3 and clinicopathologic features of colorectal cancer (such as clinical stages, tumor location, tumor size, and lymph node metastasis). Methods In colorectal cancers and adjacent normal intestinal mucosa from 59 patients, the expression levels of MEKK3 were assessed by immunohistochemistry. Results The positive expression rate of MEKK3 was 83.1% in colorectal cancer tissues, which was significantly higher than that in adjacent normal intestinal mucosa (13.6%), P0.05. There was no significant correlation between the expression of MEKK3 and the clinicopathologic features of colorectal cancer, including gender, age, tumor location, tumor size, and lymph node metastasis (P0.05). Conclusion High expression of MEKK3 is an important molecular event in colorectal cancer.
出处 《海南医学》 CAS 2011年第22期1-4,共4页 Hainan Medical Journal
基金 2011年深圳市全安区科枝立项项目(编号:20110510)
关键词 结直肠癌 MEKK3 免疫组织化学 Colorectal cancer MEKK3 Immunohistochemistry
  • 相关文献

参考文献11

  • 1Widmann C, Gibson S, Jarpe MB, et al. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human [J]. Physiol Rev, 1999, 79(1): 143-180.
  • 2Lange-Carter CA, Pleiman CM, Gardner AM, et al. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf [J]. Science, 1993, 260(5106): 315-319.
  • 3Huang Q, Ynag J, Lin Y, et al. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3 [J]. Nature Immunol, 2004, 5(1): 98-103.
  • 4Hagemann T, Wilson J, Kulbe H, et al. Macrophages induce inva- siveness of epithelial cancer cells via NF-kappa B and JNK [J]. J Immunol, 2005, 175(2): 1197-1205.
  • 5Gao J, Tian J, Lv Y, et al. Leptin induces functional activation ofcy- clooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/ AKT pathways in human endometrial cancer ceils [J]. Cancer Sci, 2009, 100(3): 389-395.
  • 6Samanta AK, IIuang H J, Le XF, et al. MEKK3 expression correlates with nuclear factor kappa B activity and with expression of anti- apoptotic genes in serous ovarian carcinoma [J]. Cancer, 2009, 115(17):3897-908.
  • 7Deacon K, Blank JL. Characterization of the mitogen-activated pro- tein kinase kinase 4 (MKK4)/c-Jun NH2-terminat kinase 1 andMKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK ki- nase 3 activates MKK3 but does not cause activation of p38 kinase in vivo [J]. J Biol Chem, 1997, 272(22): 14489-14496.
  • 8Ellinger-Ziegelbauer It, Brown K, Kelly K, et al. Direct activation of the stress-activated protein kinase (SAPK) and extracellular sig- nal-regulated protein kinase (ERK) pathways by an inducible mito- gen-activated protein Kinase/ERK kinase kinase 3 (MEKK) deriva-tive [J]. J Biol Chem, 1997, 372(5): 2668-2674.
  • 9Li YY, Hsieh LL, Tang RP, et al. Interleukin-6 (IL-6) released by macrophages induces IL-6 secretion in the human colon cancer HT-29 cell line [J]. Hum Immunol, 2009, 70(3): 151-158.
  • 10Pucci S, Mazzarelli P, Sesti F, et al. Interleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progression [J].Cell Cycle, 2009, 8(3): 473-481.

同被引文献12

  • 1Craig EA, Stevens MV, Vaillancourt RR, et al. MAP3Ksascentral regulators of cell fate during development [J]. De-velopmental Dynamics, 2008,237 (11) : 3102-3114.
  • 2Gao J,Tian J,,Lv Y,et al. Leptin induces functional ac-tivation of cy-clooxygenase-2 through JAK2/STAT3,MAPK/ERK, and PI3K/AKT pathways in human endome-trial cancer cells [J]. Cancer Sci, 2009,100 (3) : 389-395.
  • 3Samanta AK, Huang HJ, Le XF, et al. MEKK3 expres-sion correlates with nuclear factor kappa B activity and withexpression of anti-apoptotic genes in serous ovarian carcino-ma [J]. Cancer, 2009,115 (17): 3897-908.
  • 4Sun B,Moibi J A, Mak A,et al. Response of bladder car-cinoma cells to TRAIL and antisense oligonucleotide, Bcl-2or Clusterin treatments [J]. J Urol, 2009 , 181 (3) : 1361-1371.
  • 5Yang MD,Lai KC, Lai TY, et al. Phenethyl isothiocya-nate inhibits migration and invasion of human gastric cancerAGS cells through suppressing MAPK and NF-kappaB sig-nal pathways [J]. Anticancer Res, 2010, 30 ( 6): 2135-2143.
  • 6Kazuhiro N, Adam J,Kimplel, et al. PBldomain interac-tion of p62/Sequestosomel and MEKK3regulates NF-kB ac-tivation [J]. J Biol Chem, 2010,285 (3) : 2077-2089.
  • 7Sun WJ, LI HX, YU Y,et al. MEKK3is required for ly-sophosphatidic acid-induced NF-kB activation [J]. Cell Sig-nal, 2009, 21 (10): 1488-1494.
  • 8Deng Y, Yang J, McCarty M, et al. MEKK3 is requiredfor endothelium function but is not essential for tumorgrowth and angiogenesis [J]. Am J Physiol Cell Physiol,2007, 293 (4): C1404-C1411.
  • 9Kumar A, Raziuddin M, Ralhan R,et al. Discovery of de-regulation of zinc homeostasis and its associated genes in e-sophageal squamous cell carcinoma using cDNA microarray[J]. Int J Cancer, 2007,120 (2) : 230-242.
  • 10Wang G,Wang X,Yu H, etal. Small-molecule activationof the TRAIL receptor DR5 in human cancer cells [J]. NatChem Biol, 2013,9 (2): 84-89.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部